Abstract
Chronic obstructive pulmonary disease (COPD) is a complex chronic inflammatory disease of the respiratory system that affects primarily distal respiratory pathways and lung parenchyma. Smoking tobacco is a major risk factor for COPD. The relationship of HTR4 (rs3995090), HTR2A (rs6313), GRIK5 (rs8099939), GRIN2B (rs2268132), and CHRNB4 (rs1948) gene polymorphisms and COPD, as well as the contribution of these polymorphisms to the variations in quantitative characteristics that describe respiratory function, smoking behavior, and nicotine dependence was assessed in an ethnically homogeneous Tatar population. The polymorphisms of HTR2A (rs6313) (P = 0.026, OR = 1.42 for the CC genotype) and GRIN2B (rs2268132) (P = 0.0001, OR = 2.39 for the TT genotype) were significantly associated with increased risk of COPD. The AA genotype of GRIK5 (rs8099939) had a protective effect (P = 0.02, OR = 0.61). Importantly, the HTR2A (rs6313), GRIN2B (rs2268132), and GRIK5 (rs8099939) polymorphisms were only associated with COPD in smokers. Smoking index (pack-years) was significantly higher in carriers of the GRIK5 genotype AC (rs8099939) (P = 0.0027). The TT genotype of GRIN2B (rs2268132) was associated with COPD in subjects with high nicotine dependence according to the Fagerström test (P = 0.002, OR = 2.98). The TT genotype of HTR2A (rs6313) was associated with a reduced risk of the disease in the group with moderate nicotine dependence (P = 0.02, OR = 0.22). The CC genotype of HTR2A (rs6313) and the TT genotype of GRIN2B (rs2268132) were associated with higher levels of nicotine dependence according to the Fagerström test (P = 0.0011 and P = 0.037). Our results may provide insight into potential molecular mechanisms that involve the glutamate (GRIK5, GRIN2B) and serotonin (HTR2A) receptor genes in the pathogenesis of COPD.
Similar content being viewed by others
Abbreviations
- COPD:
-
chronic obstructive pulmonary disease
- VC:
-
vital capacity
- FVC:
-
forced vital capacity
- FEV1:
-
forced expiration volume in 1 second
- FTND:
-
Fagerström test for nicotine dependence
References
Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011. http://www.goldcopd.org/.
Grucza R.A., Johnson E.O., Krueger R.F., Breslau N., Saccone N.L., Chen L.S., Derringer J., Agrawal A., Lynskey M., Bierut L.J. 2010. Incorporating age at onset of smoking into genetic models for nicotine dependence: Evidence for interaction with multiple genes. Addict. Biol. 15, 346–357.
Hall F.S., Perona M.T. 2012. Have studies of the developmental regulation of behavioral phenotypes revealed the mechanisms of gene-environment interactions–Physiol. Behav. 107, 623–640.
Hall F.S., Der-Avakian A., Gould T.J., Markou A., Shoaib M., Young J.W. 2015. Negative affective states and cognitive impairments in nicotine dependence. Neurosci. Biobehav. Rev. 58, 168–185.
Quaak M., Van Schayck C.P., Knaapen A.M., Van Schooten F.J. 2009. Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases–Eur. Respir. J. 33, 468–480.
Thorgeirsson T.E., Geller F., Sulem P., Rafnar T., Wiste A., Magnusson K.P., Manolescu A., Thorleifsson G., Stefansson H., Ingason A., Stacey S.N., Bergthorsson J.T., Thorlacius S., Gudmundsson J., Jonsson T., et al. 2008. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature. 452, 638–642.
Furberg H., Kim Y., Dackor J., Boerwinkle E., Franceschini N., Ardissino D., Bernardinelli L., Mannucci P.L., Mauri F., Merlini P.A., Absher D., Assimes T.L., Fortmann S.P., Iribarren C., Knowles J.W., et al. 2010. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat. Genet. 42, 441–447.
Wolock S.L., Yates A., Petrill S.A., Bohland J.W., Blair C., Li N., Machiraju R., Huang K. Bartlett C.W. 2013. Gene–smoking interactions on human brain gene expression: Finding common mechanisms in adolescents and adults. J. Child. Psychol. Psychiatry. 54, 1109–1119.
Repapi E., Sayers I., Wain L.V., Burton P.R., Johnson T., Obeidat M., Zhao J.H., Ramasamy A., Zhai G., Vitart V., Huffman J.E., Igl W., Albrecht E., Deloukas P., Henderson J., et al. 2010. Genome-wide association study identifies five loci associated with lung function. Nat. Genet. 42, 36–44.
Hancock D.B., Eijgelsheim M., Wilk J.B., Gharib S.A., Loehr L.R., Marciante K.D., Franceschini N., vanDurme Y.M., Chen T.H., Barr R.G., Schabath M.B., Couper D.J., Brusselle G.G., Psaty B.M., Van Duijn C.M., et al. 2010. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat. Genet. 42, 45–52.
Soler Artigas M., Wain L.V., Repapi E., Obeidat M., Sayers I., Burton P.R., Johnson T., Zhao J.H., Albrecht E., Dominiczak A.F., Kerr S.M., Smith B.H., Cadby G., Hui J., Palmer L.J., et al. 2011. Effect of five genetic variants associated with lung function on the risk of chronic obstructive lung disease, and their joint effects on lung function. Am. J. Respir. Crit. Care. Med. 184, 786–795.
Wilk J.B., Shrine N.R., Loehr L.R., Zhao J.H., Manichaikul A., Lopez L.M., Smith A.V., Heckbert S.R., Smolonska J., Tang W., Loth D.W., Curjuric I., Hui J., Cho M.H., Latourelle J.C., et al. 2012. Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. Am. J. Resp. Crit. Care. Med. 186, 622–632.
Thorgeirsson T.E., Gudbjartsson D.F., Surakka I., Vink J.M., Amin N., Geller F., Sulem P., Rafnar T., Esko T., Walter S., Gieger C., Rawal R., Mangino M., Prokopenko I., Mä gi R., et al. 2010. Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat.Genet. 42, 448–453.
Pillai S.G., Ge D., Zhu G., Kong X., Shianna K.V., Need A.C., Feng S., Hersh C.P., Bakke P., Gulsvik A., Ruppert A., Lødrup Carlsen K.C., Roses A., Anderson W., Rennard S.I., et al. 2009. A genome-wide association study in chronic obstructive pulmonary disease (COPD): Identification of two major susceptibility loci. PLoS Genet. 5, e1000421.
Hodge E., Nelson C.P., Miller S., Billington C.K., Stewart C.E., Swan C., Malarstig A., Henry A.P., Gowland C., Melén E., Hall I.P., Sayers I. 2013. HTR4 gene structure and altered expression in the developing lung. Respir. Res. 14, 77.
International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10). http://www.who.int/classifications/icd/en/.
Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerström K.O. 1991. The Fagerström test for nicotine dependence: A revision of the Fagerström tolerance questionnaire. Br. J. Addict. 86, 1119–1127.
Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., Sham P.C. 2007. PLINK: A toolset for whole-genome association and population-based linkage analysis. Am. J. Hum. Genet. 81, 559–575.
StatSoft Inc. Statistica v. 6.0 Program. http://www.statistica. com.
Open Database of Single Nucleotide Polymorphisms (SNPs) and Multiple Small-scale Variations. Bethesda, MD: National Center for Biotechnology Information. http://www.ncbi.nlm.nih.gov/projects/SNP/.
Goo M.S., Scudder S.L., Patrick G.N. 2015. Ubiquitin-dependent trafficking and turnover of ionotropic glutamate receptors. Front. Mol. Neurosci. 8, 60.
Belenikin M.S., Macchiarulo A., Constantino G., Palyulin V.A., Pelliciari R., Zefirov N.S. 2002. Molecular docking of gluitamate reseptor ligands. Vestn. Mosk. Gos. Univ., Ser. 2: Khim. 43, 221–230.
Kew J.N., Kemp J.A. 2005. Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology. 179, 4–29.
Ferraguti F., Shigemoto R. 2006. Metabotropic glutamate receptors. Cell. Tissue Res. 326, 483–504.
Yosifova A., Mushiroda T., Kubo M., Takahashi A., Kamatani Y., Kamatani N., Stoianov D., Vazharova R., Karachanak S., Zaharieva I., Dimova I., Hadjidekova S., Milanova V., Madjirova N., Gerdjikov I., et al. 2011. Genome-wide association study on bipolar disorder in the Bulgarian population. Genes Brain Behav. 7, 789–797.
Gratacòs M., Costas J., de Cid R., Bayés M., González J.R., Baca-García E., de Diego Y., Fernández-Aranda F., Fernández-Piqueras J., Guitart M., Martín-Santos R., Martorell L., Menchón J.M., Roca M., Sáiz-Ruiz J., et al. 2009. Psychiatric Genetics Network Group. Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B, 808–816.
Takenouchi T., Hashida N., Torii C., Kosaki R., Takahashi T., Kosaki K. 2014. 1p34.3 deletion involving GRIK3: Further clinical implication of GRIK family glutamate receptors in the pathogenesis of developmental delay. Am. J. Med. Genet. A. 164A, 456–460.
Zhang Y., Fan M., Wang Q., He G., Fu Y., Li H., Yu S. 2015. Polymorphisms in microRNA genes and genes involving in NMDAR signaling and schizophrenia: A case-control study in Chinese Han population. Sci. Rep. 5, 12984.
Maussion G., Diallo A.B., Gigek C.O., Chen E.S., Crapper L., Théroux J.F., Chen G.G., Vasuta C., Ernst C. 2015. Investigation of genes important in neurodevelopment disorders in adult human brain. Hum. Genet. 134, 1037–1053.
Gong P., Liu J., Blue P.R., Li S., Zhou X. 2015. Serotonin receptor gene (HTR2A) T102C polymorphism modulates individuals’ perspective taking ability and autistic-like traits. Front. Hum. Neurosci. 23, 575.
Yang J., Li M.D. 2014. Association and interaction analyses of 5-HT3 receptor and serotonin transporter genes with alcohol, cocaine, and nicotine dependence using the SAGE data. Hum. Genet. 133, 905–918.
Myers R.L., Airey D.C., Manier D.H., Shelton R.C., Sanders-Bush E. 2007. Polymorphisms in the regulatory region of the human serotonin 5-HT2A receptor gene (HTR2A) influence gene expression. Biol. Psychiatry. 61, 167–173.
do Prado-Lima P.A., Chatkin J.M., Taufer M., Oliveira G., Silveira E., Neto C.A., Haggstram F., Bodanese L.C., da Cruz I.B. 2004. Polymorphism of 5HT2A serotonin receptor gene is implicated in smoking addiction. Am. J. Med. Genet. B Neuropsychiatr. Genet. 128B, 90–93.
Polina E.R., Contini V., Hutz M.H., Bau C.H. 2009. The serotonin 2A receptor gene in alcohol dependence and tobacco smoking. Drug. Alcohol. Depend. 101, 128–131.
Ramos Neto E.S., Má gulas J.O., Sousa J.J., Moura A.C., Pinto G.R., Yoshioka F.K., Canalle R., Motta F.J. 2014. Study of polymorphic variants of the serotonin 2A receptor gene (5-HT2A) and its possible effects on smoking habits of population from northeastern Brazil. Genet. Mol. Res. 13, 8268–8277.
Bayer H., Mü ller T., Myrtek D., Sorichter S., Ziegenhagen M., Norgauer J., Zissel G., Idzko M. 2007. Serotoninergic receptors on human airway epithelial cells. Am. J. Respir. Cell. Mol. Biol. 36, 85–93.
Korytina G.F., Akhmadishina L.Z., Kochetova O.V., Burduk Yu.V., Aznabaeva Yu.G., Zagidullin Sh.Z., Viktorova T.V. 2014. Association of genes involved in nicotine and tobacco smoke toxicant metabolism (CHRNA3/5, CYP2A6, and NQO1) and DNA repair (XRCC1, XRCC3, XPC, and XPA) with chronic obstructive pulmonary disease. Mol. Biol. (Moscow). 48 (6), 823–834.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © G.F. Korytina, L.Z. Akhmadishina, O.V. Kochetova, Y.G. Aznabaeva, Sh.Z. Zagidullin, T.V. Victorova, 2017, published in Molekulyarnaya Biologiya, 2017, Vol. 51, No. 4, pp. 603–614.
Rights and permissions
About this article
Cite this article
Korytina, G.F., Akhmadishina, L.Z., Kochetova, O.V. et al. Polymorphic variants of glutamate receptor (GRIK5, GRIN2B) and serotonin receptor (HTR2A) genes are associated with chronic. Mol Biol 51, 533–542 (2017). https://doi.org/10.1134/S0026893317040124
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0026893317040124